ZEN003365

· Zenith Epigenetics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZEN003365, covering 2014-11-13 to 2014-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML [Phase 1]

See pricing